|
Volumn 18, Issue SUPPL.2, 2012, Pages
|
Impact of outcomes monitoring on innovation and risk in liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
CREATININE;
ABDOMINAL SURGERY;
AGE;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL PROTOCOL;
CLINICAL TRIAL (TOPIC);
FATTY LIVER;
FUNCTIONAL STATUS;
GOVERNMENT;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEALTH INSURANCE;
HEART DEATH;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFORMED CONSENT;
LIFE SUPPORT EQUIPMENT;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
LONG TERM CARE;
NUTRITIONAL STATUS;
ORGAN DONOR;
PATIENT MONITORING;
PORTAL VEIN THROMBOSIS;
PRIORITY JOURNAL;
REGISTER;
RISK ASSESSMENT;
SMOKING;
SURGICAL RISK;
TREATMENT OUTCOME;
HUMANS;
LIVER DISEASES;
LIVER TRANSPLANTATION;
MEDICAID;
MEDICARE;
PATIENT SELECTION;
RISK ADJUSTMENT;
RISK FACTORS;
TISSUE AND ORGAN PROCUREMENT;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84868108087
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.23539 Document Type: Article |
Times cited : (15)
|
References (7)
|